XML 94 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Restatement of Previously Filed Consolidated Balance Sheet (Details) - Schedule of restatement on each financial statement
 1 Months Ended
Jun. 18, 2021
USD ($)
As Previously Reported [Member]  
Condensed Balance Sheet Statements, Captions [Line Items]  
Total assets $ 350,268,752
Total liabilities 36,900,558
Class A ordinary shares subject to redemption 308,368,190
Preferred shares
Class A ordinary shares 367
Class B ordinary shares 863
Additional paid-in capital 7,869,618
Accumulated deficit (2,761,389)
Non-controlling interest in subsidiary (109,455)
Total shareholders’ equity (deficit) 5,000,004
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) 350,268,752
Adjustment [Member]  
Condensed Balance Sheet Statements, Captions [Line Items]  
Total assets
Total liabilities
Class A ordinary shares subject to redemption 36,631,810
Preferred shares
Class A ordinary shares (367)
Class B ordinary shares
Additional paid-in capital (7,869,618)
Accumulated deficit (28,871,280)
Non-controlling interest in subsidiary
Total shareholders’ equity (deficit) (36,631,810)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit)
As Restated [Member]  
Condensed Balance Sheet Statements, Captions [Line Items]  
Total assets 350,268,752
Total liabilities 36,900,558
Class A ordinary shares subject to redemption 345,000,000
Preferred shares
Class A ordinary shares
Class B ordinary shares 863
Additional paid-in capital
Accumulated deficit (31,632,669)
Non-controlling interest in subsidiary (109,455)
Total shareholders’ equity (deficit) (31,631,806)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders’ Equity (Deficit) $ 350,268,752